Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G

PLoS Pathogens

Volumn 8, Issue 12, 2012, Pages

  Stanley, David J ^a   Bartholomeeusen, Koen ^b   Crosby, David C ^a   Kim, Dong Young ^a   Kwon, Eunju ^a   Yen, Linda ^a   Cartozo, Nathalie Caretta ^a   Li, Ming ^c   Jäger, Stefanie ^b   Mason Herr, Jeremy ^a   Hayashi, Fumiaki ^d   Yokoyama, Shigeyuki ^d,e   Krogan, Nevan J ^b,f,g   Harris, Reuben S ^c   Peterlin, Boris Matija ^b   Gross, John D ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d RIKEN   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GLADSTONE INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[4 [4 [(2, 3 DIHYDRO 1H INDEN 1 YL) AMINO] 7H PYRROLO [2, 3 D] PYRIMIDIN 7 YL] 2 HYDROXYCYCLOPENTYLMETHYL] SULFAMATE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD4 ANTIGEN; CULLIN; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; NEDD8 PROTEIN; POLYUBIQUITIN; RING BOX PROTEIN 1; RING BOX PROTEIN 2; RING FINGER PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MUTATION RATE; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; VIRION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CULLIN PROTEINS; CYCLOPENTANES; CYTIDINE DEAMINASE; HEK293 CELLS; HIV; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; PYRIMIDINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84872026925     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003085     Document Type: Article

References (61)

1. Ott M, Geyer M, Zhou Q, (2011) The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe 10: 426-435.
2. von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, et al. (2003) The protein network of HIV budding. Cell 114: 701-713.
3. Suhasini M, Reddy TR, (2009) Cellular proteins and HIV-1 Rev function. Curr HIV Res 7: 91-100.
4. Namy O, Moran SJ, Stuart DI, Gilbert RJ, Brierley I, (2006) A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting. Nature 441: 244-247.
5. Malim MH, Emerman M, (2008) HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398.
6. Jäger S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, et al. (2012) Global landscape of HIV-human protein complexes. Nature 481: 365-370.
7. Sheehy AM, Gaddis NC, Choi JD, Malim MH, (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
8. Malim MH, (2009) APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci 364: 675-687.
9. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
10. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, et al. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 78: 6073-6076.
11. Yu X, Yu Y, Liu B, Luo K, Kong W, et al. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302: 1056-1060.
12. Jäger S, Kim DY, Hultquist JF, Shindo K, LaRue RS, et al. (2012) Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 481: 371-375.
13. Zhang WY, Du J, Evans SL, Yu YK, Yu XF, (2012) T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481: 376-U159.
14. Wong WF, Kohu K, Chiba T, Sato T, Satake M, (2011) Interplay of transcription factors in T-cell differentiation and function: the role of Runx. Immunology 132: 157-164.
15. Hultquist JF, Binka M, Larue RS, Simon V, Harris RS, (2012) Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFbeta To Degrade APOBEC3 Restriction Factors. J Virol 86: 2874-2877.
16. Pickart CM, (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503-533.
17. Mehle A, Strack B, Ancuta P, Zhang C, McPike M, et al. (2004) Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem 279: 7792-7798.
18. Deshaies RJ, Emberley ED, Saha A, (2010) Control of cullin-ring ubiquitin ligase activity by nedd8. Subcell Biochem 54: 41-56.
19. Petroski MD, Deshaies RJ, (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6: 9-20.
20. Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, et al. (2009) An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458: 732-736.
21. Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, et al. (2010) Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell 37: 102-111.
22. Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, et al. (2009) E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol Cell 33: 483-495.
23. Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, et al. (2004) VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18: 3055-3065.
24. Yu Q, Konig R, Pillai S, Chiles K, Kearney M, et al. (2004) Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 11: 435-442.
25. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, et al. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424: 94-98.
26. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103.
27. Refsland EW, Hultquist JF, Harris RS, (2012) Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n. PLoS Pathog 8: e1002800.
28. DeHart JL, Bosque A, Harris RS, Planelles V, (2008) Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation. J Virol 82: 9265-9272.
29. Huthoff H, Malim MH, (2007) Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation. J Virol 81: 3807-3815.
30. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, et al. (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res 38: 4274-4284.
31. Kamura T, Burian D, Yan Q, Schmidt SL, Lane WS, et al. (2001) Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J Biol Chem 276: 29748-29753.
32. Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T, (2005) Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J Biol Chem 280: 18573-18578.
33. Calabrese MF, Scott DC, Duda DM, Grace CR, Kurinov I, et al. (2011) A RING E3-substrate complex poised for ubiquitin-like protein transfer: structural insights into cullin-RING ligases. Nat Struct Mol Biol 18: 947-949.
34. Randow F, Lehner PJ, (2009) Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11: 527-534.
35. Saha A, Deshaies RJ, (2008) Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell 32: 21-31.
36. Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, et al. (2008) Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134: 995-1006.
37. Donaldson TD, Noureddine MA, Reynolds PJ, Bradford W, Duronio RJ, (2004) Targeted disruption of Drosophila Roc1b reveals functional differences in the Roc subunit of Cullin-dependent E3 ubiquitin ligases. Mol Biol Cell 15: 4892-4903.
38. Tron AE, Arai T, Duda DM, Kuwabara H, Olszewski JL, et al. (2012) The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7. Mol Cell 46: 67-78.
39. Kurz T, Ozlu N, Rudolf F, O'Rourke SM, Luke B, et al. (2005) The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae. Nature 435: 1257-1261.
40. Kurz T, Chou YC, Willems AR, Meyer-Schaller N, Hecht ML, et al. (2008) Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation. Mol Cell 29: 23-35.
41. Scott DC, Monda JK, Grace CR, Duda DM, Kriwacki RW, et al. (2010) A dual E3 mechanism for Rub1 ligation to Cdc53. Mol Cell 39: 784-796.
42. Smith JL, Bu W, Burdick RC, Pathak VK, (2009) Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development. Trends Pharmacol Sci 30: 638-646.
43. Cao J, Isaacson J, Patick AK, Blair WS, (2005) High-throughput human immunodeficiency virus type 1 (HIV-1) full replication assay that includes HIV-1 Vif as an antiviral target. Antimicrob Agents Chemother 49: 3833-3841.
44. Nathans R, Cao H, Sharova N, Ali A, Sharkey M, et al. (2008) Small-molecule inhibition of HIV-1 Vif. Nat Biotechnol 26: 1187-1192.
45. Cen S, Peng ZG, Li XY, Li ZR, Ma J, et al. (2010) Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. J Biol Chem 285: 16546-16552.
46. Xiao Z, Ehrlich E, Luo K, Xiong Y, Yu XF, (2007) Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. FASEB J 21: 217-222.
47. Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, et al. (2011) Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J Virol 85: 11220-11234.
48. Ceccarelli DF, Tang X, Pelletier B, Orlicky S, Xie W, et al. (2011) An allosteric inhibitor of the human cdc34 ubiquitin-conjugating enzyme. Cell 145: 1075-1087.
49. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
50. Gijsbers R, Ronen K, Vets S, Malani N, De Rijck J, et al. (2010) LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther 18: 552-560.
51. Russell RA, Moore MD, Hu WS, Pathak VK, (2009) APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA. Retrovirology 6: 16.
52. Huang DT, Schulman BA, (2005) Expression, purification, and characterization of the E1 for human NEDD8, the heterodimeric APPBP1-UBA3 complex. Methods Enzymol 398: 9-20.
53. Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS, (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 17: 222-229.
54. Shlyakhtenko LS, Lushnikov AY, Li M, Lackey L, Harris RS, et al. (2011) Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3G. J Biol Chem 286: 3387-3395.
55. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
56. Sattler M, Schleucher J, Griesinger C, (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Progress in Nuclear Magnetic Resonance Spectroscopy 34: 93-158.
57. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, et al. (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59: 687-696.
58. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
59. Dominguez C, Boelens R, Bonvin AM, (2003) HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. Journal of the American Chemical Society 125: 1731-1737.
60. Mace PD, Linke K, Feltham R, Schumacher FR, Smith CA, et al. (2008) Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J Biol Chem 283: 31633-31640.
61. Albin JS, Hache G, Hultquist JF, Brown WL, Harris RS, (2010) Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function. J Virol 84: 10209-10219.